ATOSSA THERAPEUTICS, INC. — Director's Dealing 2014

Mar 5, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ATOSSA GENETICS INC (ATOS)
CIK: 0001488039
Period of Report: 2014-03-01

Reporting Person: Steinhart Richard I (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-01	Common Stock	A	22728	—	Acquired	22728	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-03-01	Stock Option (Right to Buy)	$2.20	A	16484	Acquired	2024-03-01	Common Stock (16484)	Direct

Footnotes

F1: Assuming the reporting person is still serving as a director of the company on the date of the 2014 annual meeting of stockholders, this option vests and becomes exercisable as to 100% of the underlying shares on such date.